和铂医药、乐普生物等近10家港股生物医药公司,上半年营收增速均超100%

动脉网
Sep 05

2025年上半年,港股生物医药板块表现亮眼,约110家公司中近70家营收同比增长,其中近10家公司增速超100%。和铂医药、乐普生物等公司营收增速显著,例如宜明昂科-B的营业总收入同比暴增49285.71%,康诺亚-B实现营业收入4.99亿元,同比增长812%。科济药业-B上半年营业总收入增长703.8%,主要收益来自BCMA CAR-T产品赛恺泽。和铂医药上半年总收入约7.25亿元,同比增长...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10